CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection - PubMed (original) (raw)

Review

. 2002 Feb 15:185 Suppl 1:S83-9.

doi: 10.1086/338003.

Affiliations

• PMID: 11865444
• DOI: 10.1086/338003

Review

CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection

Carlos S Subauste. J Infect Dis. 2002.

Abstract

CD40 and CD154 (CD40 ligand) are surface molecules that are central to the cross-talk between T cells and antigen-presenting cells. This article reviews the relevance of CD40-CD154 interaction for regulation of interleukin-12/interferon-gamma production in response to Toxoplasma gondii as an example of an intracellular pathogen. The manner in which defects in CD154 signaling contribute to immunosuppression and susceptibility to opportunistic infections in patients with X-linked hyper IgM syndrome and in patients with human immunodeficiency virus infection is also discussed.

PubMed Disclaimer

Similar articles

• Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection.
  Subauste CS, Wessendarp M, Smulian AG, Frame PT. Subauste CS, et al. J Infect Dis. 2001 Jun 15;183(12):1722-31. doi: 10.1086/320734. Epub 2001 May 17. J Infect Dis. 2001. PMID: 11372024
• Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients.
  Subauste CS, Wessendarp M, Portilllo JA, Andrade RM, Hinds LM, Gomez FJ, Smulian AG, Grubbs PA, Haglund LA. Subauste CS, et al. J Infect Dis. 2004 Jan 1;189(1):61-70. doi: 10.1086/380510. Epub 2003 Dec 23. J Infect Dis. 2004. PMID: 14702154
• [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
  Groeneweg M, Lankester AC, Bredius RG. Groeneweg M, et al. Ned Tijdschr Geneeskd. 2003 May 24;147(21):1009-11. Ned Tijdschr Geneeskd. 2003. PMID: 12811971 Review. Dutch.
• Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
  Lougaris V, Badolato R, Ferrari S, Plebani A. Lougaris V, et al. Immunol Rev. 2005 Feb;203:48-66. doi: 10.1111/j.0105-2896.2005.00229.x. Immunol Rev. 2005. PMID: 15661021 Review.

Cited by

• Toxoplasmosis in HIV infection: An overview.
  Basavaraju A. Basavaraju A. Trop Parasitol. 2016 Jul-Dec;6(2):129-135. doi: 10.4103/2229-5070.190817. Trop Parasitol. 2016. PMID: 27722101 Free PMC article.
• Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry.
  Portillo JA, Okenka G, Kern TS, Subauste CS. Portillo JA, et al. Mol Vis. 2009 Jul 17;15:1383-9. Mol Vis. 2009. PMID: 19626134 Free PMC article.
• CD40 and the immune response to parasitic infections.
  Subauste CS. Subauste CS. Semin Immunol. 2009 Oct;21(5):273-82. doi: 10.1016/j.smim.2009.06.003. Epub 2009 Jul 18. Semin Immunol. 2009. PMID: 19616968 Free PMC article. Review.
• Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.
  Lago EG, Conrado GS, Piccoli CS, Carvalho RL, Bender AL. Lago EG, et al. Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):345-51. doi: 10.1007/s10096-008-0631-2. Epub 2008 Oct 15. Eur J Clin Microbiol Infect Dis. 2009. PMID: 18855029

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc

• Research Materials

  • NCI CPTC Antibody Characterization Program